KRAS and lung carcinoma: Glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme, regulates NADPH/NADP + ratios and is implicated in tumorigenesis, particularly in KRAS-driven, LKB1-deficient lung cancer [28].